Safety study in dogs at the University of Copenhagen
Panion develops an innovative gene therapy treatment for dogs with drug-resistant epilepsy. To move from preclinical studies and into the clinical phase with treatment of family dogs suffering from true epilepsy, the product must be shown to be safe for dogs. Adequate safety data for the investigators and responsible hospital clinics must therefore be provided by Panion. “We have started a new experimental dog study to produce the requested safety data and to expand our understanding of the product. The study is conducted under the lead of Associate Professor David Woldbye from